X4 Pharmaceuticals (XFOR) Return on Sales (QoQ) (2020 - 2025)

X4 Pharmaceuticals (XFOR) Return on Sales (QoQ) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,222.41 Bn 67,222.13 Bn -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.12 Bn 466.33 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.84 Bn 114.59 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.89 Bn 61.14 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 55.83 Bn 50.64 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.34 Bn 34.34 Bn 959.66 Mn
10 X4 Pharmaceuticals 167.48 Mn -49.57 Mn 2.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.00
Sep 30, 2025 -4.00
Jun 30, 2025 -13.00
Mar 31, 2025 28.00
Dec 31, 2024 38.00
Sep 30, 2024 -227.00
Dec 31, 2020 -3.00
Sep 30, 2020 0.00
Jun 30, 2020 -15.00